This is a continuation divisional application of application Ser. No. 09/053,866, filed Apr. 1, 1998 now U.S. Pat. No. 6,111,075.
The government may have certain rights in this application by virtue of federal funding under Grant No. 5 R01 HL15919-23 (National Institutes of Health)
Number | Name | Date | Kind |
---|---|---|---|
5011912 | Hopp et al. | Apr 1991 | A |
Entry |
---|
U.S. application No. 09/032,397, Coughlin et al., filed Feb. 27, 1998. |
Vu et al., “Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation,” Cell 64:1057-1068, Mar. 22, 1991. |
Rasmussen et al., “cDNA cloning and expression of a hamster α-thrombin receptor coupled to Ca2+mobilization,” FEBS Lett. 288:123-128, Aug., 1991. |
Nystedt et al., “Molecular cloning of a potential proteinase activated receptor,” Proc. Nat'l Acad. Sci. USA 91:9208-9212, Sep. 1994. |
Vu et al., “Domains specifying thrombin-receptor interaction,” Nature 353:674-677, Oct. 17, 1997. |
Connolly et al., “Role of the thrombin receptor in development and evidence for a second receptor,” Nature 381:516-519, Jun. 6, 1996. |
Coughlin, “Protease activated receptors start a family,” Proc. Nat'l Acad. Sci. USA 91:9200-9202, Sep., 1994. |
Molino et al., “Endothelial cell thrombin receptors and PAR-2,” J. Biol. Chem. 272:11133-11141, Apr. 25, 1997. |
Gerszten et al., “Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface,” Nature 368:648-651, Apr. 14, 1994. |
Ishii et al., “Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase,” J. Biol. Chem. 269:1125-1130, Jan. 14, 1994. |
Probst et al., “Sequence alignment of the G-protein coupled receptor superfamily,” DNA Cell Biol. 11:1-20, 1997. |
Ishihara et al., “Protease-activated receptor 3 is a second thrombin receptor in humans,” Nature 386:502-506, Apr. 3, 1997. |
EST from Incyte Pharmaceuticals, Inc., 373881. |
EST from Incyte Pharmaceuticals, Inc., 2189250. |
EST from Incyte Pharmaceuticals, Inc., 2899749. |
EST from Incyte Pharmaceuticals, Inc., 3218437. |